- Report
- April 2022
- 180 Pages
Global
From €5747EUR$5,950USD£4,915GBP
From €3077EUR$3,185USD£2,631GBP
€4395EUR$4,550USD£3,758GBP
- Report
- February 2024
- 80 Pages
India
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 102 Pages
India
From €4588EUR$4,750USD£3,923GBP
- Report
- April 2023
- 102 Pages
India
From €4588EUR$4,750USD£3,923GBP
- Report
- August 2022
- 111 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- March 2023
- 159 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- November 2022
- 120 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- October 2019
- 140 Pages
Global
From €1449EUR$1,500USD£1,239GBP
- Report
- January 2024
- 124 Pages
Global
From €3500EUR$3,881USD£3,098GBP
- Report
- June 2023
- 390 Pages
Global
From €5535EUR$5,730USD£4,733GBP
- Report
- September 2019
Global
From €5187EUR$5,370USD£4,436GBP
- Report
- December 2021
- 136 Pages
Global
From €4347EUR$4,500USD£3,717GBP
The Bulk Drug market is a segment of the Pharmaceutical Manufacturing industry that focuses on the production of active pharmaceutical ingredients (APIs). Bulk Drugs are the raw materials used to create finished pharmaceutical products, such as tablets, capsules, and injectables. Bulk Drugs are produced in large quantities and are typically sold to pharmaceutical companies for further processing.
The Bulk Drug market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the APIs. The market is also subject to fluctuations in demand, as the demand for pharmaceutical products is often affected by changes in the healthcare industry.
Notable companies in the Bulk Drug market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Other major players include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more
